Antithrombotic treatment management in patients with intracerebral hemorrhage: reversal and restart.
CONCLUSION: Although no one can deny the usefulness of antithrombotic therapy a therapeutic strategy should be developed in order to optimize the clinical decision of stopping, reversing and restarting antithrombotic treatment. This review concludes in strong recommendations, yet a multidisciplinary panel by a stroke physician or neurologist, a cardiologist, a neuroradiologist and a neurosurgeon should evaluate the benefits and the risks for each patient and decide the best therapeutic strategy.
PMID: 27917716 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Giakoumettis D, Alexiou GA, Vrachatis DA, Themistoklis K, Stathis P, Vavuranakis M, Themistocleous MS Tags: Curr Pharm Des Source Type: research
More News: Atrial Fibrillation | Brain | Cardiology | Drugs & Pharmacology | Heart | Hemorrhagic Stroke | Neurology | Neurosurgery | Stroke | Thrombosis